nach oben

Applied Health Economics and Health Policy

Erschienen in:

01.12.2016 | Letter to the Editor

Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”

verfasst von: Suzanne Laplante, Frank X. Liu, Bruce Culleton, Angelito Bernardo, Denise King, Pollyanna Hudson

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Excerpt

We appreciate Gandjour’s comment [1] on our systematic review of the published literature on the cost effectiveness of high-dose hemodialysis (HD) [2]. We understand his concern regarding the potential impact of high-dose HD-associated survival benefit on future dialysis costs, as well as the perception that this potential impact may not have been sufficiently discussed in our article [1]. …

Gandjour A. Comment on “The cost effectiveness of high-dose versus conventional haemodialysis: a systematic review”. Appl Health Econ Health Policy. 2016:1–2. doi:10.1007/s40258-016-0273-y.CrossRef

Laplante S, Liu FX, Culleton B, et al. The cost effectiveness of high-dose versus conventional haemodialysis: a systematic review. Appl Health Econ Health Policy. 2016;14(2):185–93.CrossRefPubMed

Blagg CR, Kjellstrand CM, Ting GO, et al. Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Hemodial Int. 2006;10:371–4.CrossRefPubMed

Nesrallah GE, Lindsay RM, Cuerden MS, et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol. 2012;23:696–705.CrossRefPubMedPubMedCentral

Marshall MR, Hawley CM, Kerr PG, et al. Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis. 2011;58:782–93.CrossRefPubMed

Weinhandl ED, Liu J, Gilbertson DT, et al. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23:895–904.CrossRefPubMedPubMedCentral

Liu FX, Treharne C, Arici M, et al. High-dose hemodialysis versus conventional in- hemodialysis: a cost-utility analysis from a UK payer perspective. Value Health. 2015;18:17–24.CrossRefPubMed

Johansen KL, Zhang R, Huang Y, et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int. 2009;76:984–90.CrossRefPubMed

Titel: Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”
verfasst von: Suzanne Laplante
Frank X. Liu
Bruce Culleton
Angelito Bernardo
Denise King
Pollyanna Hudson
Publikationsdatum: 01.12.2016
Verlag: Springer International Publishing
Erschienen in: Applied Health Economics and Health Policy / Ausgabe 6/2016
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI: https://doi.org/10.1007/s40258-016-0284-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

The Cost and Outcome Effectiveness of Total Hip Replacement: Technique Choice and Volume–Output Effects Matter

Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany

A Review of “Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course”

India’s Proposed Universal Health Coverage Policy: Evidence for Age Structure Transition Effect and Fiscal Sustainability

Acknowledgement to Referees

Comment on: “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”